Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Apr;9(2):147-66.
doi: 10.1007/BF01068079.

Evidence of nonlinearity in digoxin pharmacokinetics

Free article

Evidence of nonlinearity in digoxin pharmacokinetics

J G Wagner et al. J Pharmacokinet Biopharm. 1981 Apr.
Free article

Abstract

Six normal male volunteers received 0.5 mg label doses of digoxin as (a) a bolus intravenous injection over 2 min, (b) a constant rate intravenous infusion over 1 hr, (c) a constant rate intravenous infusion over 3 h, and (d) a solution in 5% dextrose given orally. Plasma concentrations of digoxin were measured by radioimmunoassay for a 4 day period and urinary excretion for a 6 day period after the single doses. The mean (coefficient of variation) total areas under the plasma concentration-time curves per 0.5 mg of digoxin were (a) 35.55 (14.8%), (b) 30.20 (27.7%), (c) 25.80 (35.5%), and (d) 15.47 (49.9%); the means differed significantly (0.01 greater than p greater than 0.005). The mean (coefficient of variation) total amounts excreted in the urine as a fraction of the dose were (a) 0.689 (6.31%), (b) 0.517 (20.4%), (c) 0.588 (16.8%), and (d) 0.374 (23.4%); the means differed significantly (p less than 0.001). Both the total clearance and the nonrenal clearance of digoxin differed significantly with the method of intravenous administration. The slower the rate of input of digoxin to the body, the greater were both the total clearance and the nonrenal clearance of the drug, which strongly suggests nonlinear pharmacokinetics.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1976 Sep;20(3):253-9 - PubMed
    1. Am J Cardiol. 1978 Jul;42(1):129-36 - PubMed
    1. J Clin Invest. 1951 Mar;30(3):305-11 - PubMed
    1. Clin Pharmacol Ther. 1980 Feb;27(2):219-23 - PubMed
    1. Eur J Clin Pharmacol. 1975 Oct 10;9(1):39-47 - PubMed

Publication types

LinkOut - more resources